Tuesday 03 Dec, 2024 10:47 PM
Site map | Locate Us | Login
   CRISIL Ratings assigns 'AAA' rating to subordinated debt of ICICI Pru Life with 'stable' outlook    CRISIL Ratings reaffirms Ramco Inds 'A1+' rating    Swiggy rises after Q2 net loss narrows to Rs 625 cr    Granules India drops after USFDA's 'OAI' status to Gagillapur unit    Granules India Ltd leads losers in 'A' group    Muthoot Capital Services to allot NCDs upto Rs 110 cr    TBO Tek drops after block deal    AKI India Ltd leads losers in 'B' group    NBCC bags work order worth Rs 213 cr    Volumes soar at HEG Ltd counter    Real Estate stocks slide    FMCG shares fall    Pricol gains after arm to acquire Sundaram Auto Components' unit    C E Info Systems extends losses on B2C business spin-off plan    Zydus Lifesciences Ltd spurts 1.03%, rises for third straight session 
Saravan Stocks
       
Mid - Session
Market behaviours during the course of the trading session.
Barometers turn rangebound; pharma shares decline
18-Nov-24   14:32 Hrs IST

The headline equity indices traded in a narrow range with modest losses in mid-afternoon trade. The Nifty traded below the 23,500 level. Pharma shares witnessed selling pressure for the fifth consecutive trading session.

At 14:30 IST, the barometer index, the S&P BSE Sensex declined 211.60 points or 0.29% to 77,366.38. The Nifty 50 index lost 63.50 points or 0.27% to 23,469.20.

In the broader market, the S&P BSE Mid-Cap index shed 0.13% and the S&P BSE Small-Cap index fell 0.53%.

The market breadth was negative. On the BSE, 1,669 shares rose and 2,382 shares fell. A total of 141 shares were unchanged.

Buzzing Index:

The Nifty Pharma index lost 0.63% to 21,615.20. The index dropped 4.11% in five consecutive trading sessions.

Dr Reddys Laboratories (down 2.11%), Biocon (down 2.01%), Cipla (down 1.56%), Glenmark Pharmaceuticals (down 1.22%) and Sun Pharmaceuticals Industries (down 1.08%), Zydus Lifesciences (down 0.55%), Aurobindo Pharma (down 0.50%), Natco Pharma (down 0.48%), Gland Pharma (down 0.12%) and Abbott India (down 0.08%) declined.

On the other hand, Ipca Laboratories (up 3.12%), Ajanta Pharma (up 1.64%) and Mankind Pharma (up 1.16%) edged higher.

Numbers to Track:

The yield on India's 10-year benchmark federal paper advanced 1.58% to 6.935 as compared with previous close 6.827.

In the foreign exchange market, the rupee edged higher against the dollar. The partially convertible rupee was hovering at 84.3950, compared with its close of 84.4600 during the previous trading session.

MCX Gold futures for 5 December 2024 settlement rose 0.70% to Rs 74,460.

The US Dollar index (DXY), which tracks the greenback's value against a basket of currencies, was down 0.02% to 106.66.

The United States 10-year bond yield added 0.50% to 4.451.

In the commodities market, Brent crude for November 2024 settlement gained 7 cents or 0.10% to $71.11 a barrel.

Stocks in Spotlight:

Hinduja Global Solutions (HGS) tumbled 7.45% after the company reported a consolidated net loss of Rs 50.51 crore in Q2 FY25 as against a net profit of Rs 18.43 crore in Q2 FY24. Revenue from operations slipped 7.85% to Rs 1,087.15 in Q2 FY25 as against Rs 1,179.86 crore posted in the second quarter of FY24.

Rail Vikas Nigam (RVNL) declined 1.04%. The company informed that it has received letter of acceptance (LoA) from South Central Railway for construction project worth Rs 294.94 crore.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 37273587
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd